AIM
ELV icon

Alambic Investment Management’s Elevance Health ELV Stock Holding History

Alambic Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,300
Closed -$295K – 177
2020
Q1 		$295K Buy
+1,300
New +$354K 0.71% 56
2017
Q4 		– Sell
-3,850
Closed -$731K – 472
2017
Q3 		$731K Sell
3,850
-660
-15% -$126K 0.08% 310
2017
Q2 		$848K Buy
+4,510
New +$810K 0.1% 292

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Alambic Investment Management's ELV Position: Q2 2020 in Review

Alambic Investment Management sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 1,300 shares — an estimated $295K sold.

Alambic Investment Management first reported a position in ELV in Q2 2017 and held it in 3 quarters. The position peaked at $848K in Q2 2017. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • Alambic Investment Management reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • Alambic Investment Management sold 1,300 Elevance Health shares in Q2 2020, an estimated $295K.
  • Alambic Investment Management first reported a position in Elevance Health in Q2 2017 and held it in 3 quarters.
  • Alambic Investment Management's Elevance Health position peaked at $848K in Q2 2017.
  • 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Alambic Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.